Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
06/2003
06/05/2003WO2003020908A3 Multi-lineage directed induction of bone marrow stromal cell differentiation
06/05/2003WO2002081007A3 Methods of isolating blood components using a centrifuge and uses thereof
06/05/2003WO2002064157A9 Localized myocardial injection method for treating ischemic myocardium
06/05/2003WO2002060932A3 A serpin in bifidobacteria
06/05/2003WO2002058712A3 Probiotic compounds derived from lactobacillus casei strain ke01
06/05/2003US20030106082 Transgenic stem cells, formed by dissociating blastomeres, are cultured, impregnated within surrogate; animals models; gene therapy
06/05/2003US20030106081 Transferring dipolid nucleus arrested oocyte in metaphase of meiosis for regeneration of animals embryos/cloning
06/05/2003US20030104997 Contacting the formed endodermal/neuronal precursor cell with endodermal differentiation-inducing compound; insulin-secreting pancreatic islet cell, transfecting cell for gene therapy
06/05/2003US20030104625 Novel oncolytic adenoviral vectors
06/05/2003US20030104624 Novel vector constructs
06/05/2003US20030104619 Hypoxia-mediated neurogenesis
06/05/2003US20030104616 Isolation of inner cell mass for the establishment of human embryonic stem cell (hESC) lines
06/05/2003US20030104568 Monitoring electrical transfer between transgenic cell and heart muscle tissue; electroconductivity analysis; tissue engineering
06/05/2003US20030104500 Enzymatic assays for screening anti-cancer agents
06/05/2003US20030104406 Modified and stabilized GDF propeptides and uses thereof
06/05/2003US20030104366 Polypeptides for use in the diagnosis and prevention of tumors; antiproliferative agents
06/05/2003US20030104349 Manual processing systems and methods for providing blood components conditioned for pathogen inactivation
06/05/2003US20030104339 Periosteal distraction
06/05/2003US20030104091 Probiotic formulation and method for reduction of pathogenic bacteria
06/05/2003US20030104033 Contain caseinate and another protein, preferably soybean protein or whey; reduced rate of creaming and an enhanced shelf life.
06/05/2003US20030104007 Pseudopterosin compounds of Symbiodinium spp isolated from Pseudopterogorgia elisabethae
06/05/2003US20030103997 Can be used to inhibit the infectivity, replication and cytopathic effects of a virus, such as a retrovirus, specifically HIV-1 or HIV-2, in the treatment or prevention of viral infection
06/05/2003US20030103989 Immunising pregnant mammal with antigen by any two routes of administration selected from intramammary, intraperitoneal and intramuscular and immunising mammal with antigen by third administration route, all three routes being different
06/05/2003US20030103952 Anaerobe targeted enzyme-mediated prodrug therapy
06/05/2003US20030103951 Cardiac muscle regeneration using mesenchymal stem cells
06/05/2003US20030103949 Cell proliferation
06/05/2003US20030103947 Stem cells obtained from bone which differentiate into cells of more than one connective tissue type
06/05/2003US20030103943 Multiple site delivery of adenoviral vector for the induction of angiogenesis
06/05/2003US20030103942 Comprises recombinant adeno-associated virus vectors encoding TNF antagonist; antiinflammatory agents for connective tissues and joints
06/05/2003US20030103939 For enhanced transduction of eukaryotic cells; gene expression
06/05/2003US20030103900 Using computer data; determination, calibration, diagnosis
06/05/2003CA2852277A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003CA2468511A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof
06/05/2003CA2468424A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof
06/05/2003CA2468310A1 Eb matrix production from animal tissue and its use for tissue repair
06/05/2003CA2468292A1 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
06/05/2003CA2468197A1 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
06/05/2003CA2468181A1 Hydroperylene derivatives
06/05/2003CA2467397A1 Flavivirus vaccine delivery system
06/04/2003EP1316319A1 A novel gene therapy agent for haemophilia b and its preparation method
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315835A2 Directed differentiation of embryonic cells
06/04/2003EP1315830A2 Compositions and methods for targeting peptides in humans in vivo
06/04/2003EP1315829A1 Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
06/04/2003EP1315812A2 Modified polypeptides stabilized in a desired conformation and methods for producing same
06/04/2003EP1315758A2 Methods and reagents for protease inhibition
06/04/2003EP1315756A2 Electroprocessed fibrin-based matrices and tissues
06/04/2003EP1315755A1 Anti-angiogenic peptides
06/04/2003EP1315749A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport
06/04/2003EP1315537A1 Method and system for myocardial infarction repair
06/04/2003EP1315521A2 Method for improving the efficacy of artificial insemination of non-human animals
06/04/2003EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
06/04/2003EP1315510A2 Methods and compositions for the repair and/or regeneration of damaged myocardium
06/04/2003EP1135177B1 Porous composite matrix and the production and use thereof
06/04/2003EP1030676A4 Bonding of cartilaginous matrices using isolated chondrocytes
06/04/2003EP0967987B1 Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents
06/04/2003EP0895476B1 Hsv mutant 1716 for the treatment of mesotheliomas
06/04/2003EP0850298B1 Neural transplantation using pluripotent neuroepithelial cells
06/04/2003EP0765398B1 Population of cells enriched for myeloid and/or lymphoid progenitors and methods of making and using
06/04/2003EP0571602B1 Dimer of molecular variant of apolipoprotein and processes for the production thereof
06/04/2003CN1422332A Human ovarian mesothelial cells and methods of isolation and uses thereof
06/04/2003CN1422121A Protein stabilised emulsions
06/04/2003CN1421232A Nutritive health food with functions of reducing blood fat and delaying senility and its prepn process
06/04/2003CN1421230A Granulation promoting and pus drawing out ointment
06/04/2003CN1421222A Chinese medicine composition for treating tumor
06/04/2003CN1421219A Chinese medicine for treating women's ovary cancer and uterine myoma
06/04/2003CN1421163A Prepn of health food with hair blackening function
06/04/2003CN1421138A Disinfectant tincture
06/04/2003CN1110564C Adenovirus without viable contaminant particle, preparation and use thereof
06/04/2003CN1110563C Process for producing gene engineering leukocyte medicines from silkworm
06/04/2003CN1110556C Isolated nucleic acid molecules for coding tumor rejection antigen precursor MAGE-3 and use thereof
06/04/2003CN1110547C Strains of bacteria, pharmaceutical composition containing them, and use of the same strains in preventing and treating diseases
06/04/2003CN1110316C Black plaster and preparing process thereof
06/04/2003CN1110315C Fracture-setting medicine and its preparing method
06/04/2003CN1110313C Medicine for preventing and curing cholesthiasis disease
06/04/2003CN1110310C Medicated wine for treating atrophic arthritis
06/04/2003CN1110309C Medicine for treating psoriasis and its preparing process
06/03/2003US6573368 Compositions for the treatment and diagnosis of breast cancer and methods for their use
06/03/2003US6573241 Therapeutic agent for the suppression of snoring noises
06/03/2003US6573100 DNA vectors without a selection marker gene
06/03/2003US6573083 By ingesting a laxative effective dosage of non-pathogenic Escherichia coli to produce a weight loss of up to two pounds within one week
06/03/2003US6573079 Methods and interferon deficient substrates for the propagation of viruses
06/03/2003US6572895 Treatment of congestive heart failure
06/03/2003US6572883 Illness curative comprising fermented fish
06/03/2003US6572856 Classic complement pathway, C3 convertase
06/03/2003US6572854 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
06/03/2003US6572605 Implantable device and use therefor
05/2003
05/30/2003WO2003044183A1 Interleukin-2 gene transferred lymphokine activated killer cells
05/30/2003WO2003044181A1 Improvement of viability and function of pancreatic islets
05/30/2003WO2003044164A2 Cell substrates and methods of use thereof
05/30/2003WO2003043675A1 Creation of tissue engineered female reproductive organs
05/30/2003WO2003043674A1 Augmentation of organ function
05/30/2003WO2003043669A1 Composition and method for treatment of wounds
05/30/2003WO2003043649A1 Removal promoters and inhibitor for apoptosis cells in vivo
05/30/2003WO2003043622A1 Substituted bicyclo[3.3.1]nonan-2,4,9-triones as pharmaceutical active ingredients
05/30/2003WO2003043587A2 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna
05/30/2003WO2003043576A2 Flowable osteogenic and chondrogenic compositions
05/30/2003WO2003043574A2 Pharmaceutical compositions in particulate form
05/30/2003WO2003043571A2 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation
1 ... 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 ... 1259